Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 91

Similar articles for PubMed (Select 21444925)

1.

Plasma kallikrein mediates retinal vascular dysfunction and induces retinal thickening in diabetic rats.

Clermont A, Chilcote TJ, Kita T, Liu J, Riva P, Sinha S, Feener EP.

Diabetes. 2011 May;60(5):1590-8. doi: 10.2337/db10-1260. Epub 2011 Mar 28.

2.

Specific retinal diacylglycerol and protein kinase C beta isoform modulation mimics abnormal retinal hemodynamics in diabetic rats.

Bursell SE, Takagi C, Clermont AC, Takagi H, Mori F, Ishii H, King GL.

Invest Ophthalmol Vis Sci. 1997 Dec;38(13):2711-20.

PMID:
9418723
3.

Intraocular hemorrhage causes retinal vascular dysfunction via plasma kallikrein.

Liu J, Clermont AC, Gao BB, Feener EP.

Invest Ophthalmol Vis Sci. 2013 Feb 7;54(2):1086-94. doi: 10.1167/iovs.12-10537.

4.

Hepatocyte growth factor induces retinal vascular permeability via MAP-kinase and PI-3 kinase without altering retinal hemodynamics.

Clermont AC, Cahill M, Salti H, Rook SL, Rask-Madsen C, Goddard L, Wong JS, Bursell D, Bursell SE, Aiello LP.

Invest Ophthalmol Vis Sci. 2006 Jun;47(6):2701-8.

PMID:
16723489
5.

Plasma kallikrein mediates angiotensin II type 1 receptor-stimulated retinal vascular permeability.

Phipps JA, Clermont AC, Sinha S, Chilcote TJ, Bursell SE, Feener EP.

Hypertension. 2009 Feb;53(2):175-81. doi: 10.1161/HYPERTENSIONAHA.108.117663. Epub 2009 Jan 5.

6.

Endothelin-3 regulation of retinal hemodynamics in nondiabetic and diabetic rats.

Mori F, King GL, Clermont AC, Bursell DK, Bursell SE.

Invest Ophthalmol Vis Sci. 2000 Nov;41(12):3955-62.

PMID:
11053299
7.

Regulation of retinal hemodynamics in diabetic rats by increased expression and action of endothelin-1.

Takagi C, Bursell SE, Lin YW, Takagi H, Duh E, Jiang Z, Clermont AC, King GL.

Invest Ophthalmol Vis Sci. 1996 Nov;37(12):2504-18.

PMID:
8933767
8.

Plasma kallikrein-kinin system and diabetic retinopathy.

Liu J, Feener EP.

Biol Chem. 2013 Mar;394(3):319-28. doi: 10.1515/hsz-2012-0316. Review.

PMID:
23362193
11.

Intravitreal bevacizumab (Avastin) therapy for persistent diffuse diabetic macular edema.

Haritoglou C, Kook D, Neubauer A, Wolf A, Priglinger S, Strauss R, Gandorfer A, Ulbig M, Kampik A.

Retina. 2006 Nov-Dec;26(9):999-1005.

PMID:
17151486
12.

Reduction of experimental diabetic vascular leakage by delivery of angiostatin with a recombinant adeno-associated virus vector.

Shyong MP, Lee FL, Kuo PC, Wu AC, Cheng HC, Chen SL, Tung TH, Tsao YP.

Mol Vis. 2007 Jan 31;13:133-41.

13.

Angiotensin AT(1) receptor antagonism normalizes retinal blood flow and acetylcholine-induced vasodilatation in normotensive diabetic rats.

Horio N, Clermont AC, Abiko A, Abiko T, Shoelson BD, Bursell SE, Feener EP.

Diabetologia. 2004 Jan;47(1):113-23. Epub 2003 Nov 14.

PMID:
14618237
14.

Intravitreal injection of corticosteroid attenuates leukostasis and vascular leakage in experimental diabetic retina.

Tamura H, Miyamoto K, Kiryu J, Miyahara S, Katsuta H, Hirose F, Musashi K, Yoshimura N.

Invest Ophthalmol Vis Sci. 2005 Apr;46(4):1440-4.

PMID:
15790913
15.

The in vivo effect of endothelins on retinal circulation in nondiabetic and diabetic rats.

Bursell SE, Clermont AC, Oren B, King GL.

Invest Ophthalmol Vis Sci. 1995 Mar;36(3):596-607.

PMID:
7890491
16.
17.

Intravitreal injection of erythropoietin protects against retinal vascular regression at the early stage of diabetic retinopathy in streptozotocin-induced diabetic rats.

Mitsuhashi J, Morikawa S, Shimizu K, Ezaki T, Yasuda Y, Hori S.

Exp Eye Res. 2013 Jan;106:64-73. doi: 10.1016/j.exer.2012.11.001. Epub 2012 Nov 21.

PMID:
23178551
18.

Long-term effect of intravitreal bevacizumab (avastin) in patients with chronic diffuse diabetic macular edema.

Kook D, Wolf A, Kreutzer T, Neubauer A, Strauss R, Ulbig M, Kampik A, Haritoglou C.

Retina. 2008 Oct;28(8):1053-60. doi: 10.1097/IAE.0b013e318176de48.

PMID:
18779710
19.

Intravitreal injection of exendin-4 analogue protects retinal cells in early diabetic rats.

Zhang Y, Zhang J, Wang Q, Lei X, Chu Q, Xu GT, Ye W.

Invest Ophthalmol Vis Sci. 2011 Jan 5;52(1):278-85. doi: 10.1167/iovs.09-4727.

PMID:
20688733
20.

Nanoparticle-mediated expression of an angiogenic inhibitor ameliorates ischemia-induced retinal neovascularization and diabetes-induced retinal vascular leakage.

Park K, Chen Y, Hu Y, Mayo AS, Kompella UB, Longeras R, Ma JX.

Diabetes. 2009 Aug;58(8):1902-13. doi: 10.2337/db08-1327. Epub 2009 Jun 2.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk